Results 21 to 30 of about 1,278 (131)
Implantable Drug Delivery Systems for Skeletal Muscles and Eyes
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov +8 more
wiley +1 more source
Progression and topographic subtypes of Terrien marginal degeneration
Abstract Purpose To report long‐term outcomes and to search for immunological and genetic risk factors in Terrien marginal degeneration (TMD). Methods Retrospective, in part prospective, hospital‐based longitudinal follow‐up study of 32 eyes of 16 Finnish patients from 2012 to 2023. Median follow‐up was 7.3 years (range, 0.3–15.2).
Minna Ruutila +8 more
wiley +1 more source
Autogenous labial mucous membrane and banked scleral patch grafting for exposed retinal explants [PDF]
Following retinal detachment surgery, exposure of the scleral explant is uncommon and usually requires its removal. In patients with a history of multiple retinal detachment procedures or continuing vitreoretinal traction removal of an explant can lead to retinal redetachment.
J R, Murdoch +3 more
openaire +2 more sources
Drug‐Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper
ABSTRACT Various systemic and topical medications can induce ocular and periocular cutaneous adverse effects (AEs), ranging from mild to severe. These AEs may lead to ocular surface (OS) damage and, in some cases, life‐threatening complications. Drug‐induced ocular adverse reactions are generally classified into two primary categories: toxic reactions ...
Andrea Leonardi +16 more
wiley +1 more source
Drug Delivery Technologies for the Treatment of Age‐Related Macular Degeneration
There are multiple therapeutic agents available for the treatment of both dry age‐related macular degeneration (AMD) and wet AMD. It is essential to continue innovation by introducing new drug delivery technologies that can incorporate those along with patient compliance and the accessibility of the technology into the early stages of research and ...
J Jesus Rodriguez‐Cruz +4 more
wiley +1 more source
This study demonstrates that continuous intravenous infusion of hepatocyte growth factor can significantly reduce liver fibrosis in rats. This treatment promotes hepatocyte regeneration and reduces harmful inflammation, offering promising potential as a therapy for liver cirrhosis in humans. ABSTRACT Aim Liver cirrhosis is a severe condition that often
Oki Taniyama +15 more
wiley +1 more source
Recurrent scleral patch graft shrinkage and Ahmed valve tube exposure
Aim: To report a case of recurrent Ahmed glaucoma valve (AGV) tube exposure dueto scleral patch graft (SPG) melt Background: AGV is a useful modality in the management of medically refractory glaucoma. Human donor SPG has been employed to cover the external portion of the tube to prevent its exposure. Case Description : A 23 year old male ...
openaire +2 more sources
This review highlights recent progress in piezoelectric materials for regenerative medicine, emphasizing their ability to convert mechanical stimuli into bioelectric signals that promote tissue repair. Key discussions cover the intrinsic piezoelectric properties of biological tissues, co‐stimulation cellular mechanisms for tissue regeneration, and ...
Xinyu Wang +3 more
wiley +1 more source
Internal closure of a posterior perforation using amniotic membrane: A novel surgical technique
Acta Ophthalmologica, Volume 104, Issue 2, Page 236-238, March 2026.
J. S. Suwandi +7 more
wiley +1 more source
Abstract Purpose To investigate the long‐term effects and dynamic changes in scleral thickness above the T‐haptic after sutureless scleral‐fixated intraocular lens (sSFIOL) implantation using the FIL‐SFF Carlevale lens. Setting Single‐centre, single‐surgeon, prospective clinical trial, Department of Ophthalmology, Medical University of Vienna, Austria.
Markus Schranz +5 more
wiley +1 more source

